Cargando…
Carglumic Acid Contributes to a Favorable Clinical Course in a Case of Severe Propionic Acidemia
Propionic acidemia (PA) is manifested as an abnormal accumulation of propionic acid and its metabolites, including methylcitrate, 3-hydroxypropionic acid, and propionylglycine, and is caused by a defect of propionyl-CoA carboxylase. PA is complicated by acute life-threatening metabolic crises, which...
Autores principales: | Kido, Jun, Matsumoto, Shirou, Nakamura, Kimitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085357/ https://www.ncbi.nlm.nih.gov/pubmed/32231837 http://dx.doi.org/10.1155/2020/4709548 |
Ejemplares similares
-
Long-term effectiveness of carglumic acid in patients with propionic acidemia (PA) and methylmalonic acidemia (MMA): a randomized clinical trial
por: Alfadhel, Majid, et al.
Publicado: (2021) -
Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial
por: Nashabat, Marwan, et al.
Publicado: (2019) -
Clinical Course and Nutritional Management of Propionic and Methylmalonic Acidemias
por: Mobarak, Amira, et al.
Publicado: (2020) -
Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients
por: Grünert, Sarah C, et al.
Publicado: (2013) -
Severity modeling of propionic acidemia using clinical and laboratory biomarkers
por: Shchelochkov, Oleg A., et al.
Publicado: (2021)